Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in Girls Living With HIV
Evaluating quadrivalent human papillomavirus vaccine seroresponses among 35 girls living with HIV (9–13 years of ages)
View PublicationEvaluating quadrivalent human papillomavirus vaccine seroresponses among 35 girls living with HIV (9–13 years of ages)
View PublicationEliciting perspectives on CVD research participation among a community-sample of women with or at risk for HIV, and to apply acquired insights toward the development of an evidence-based campaign empowering older women with HIV to participate in a large-scale CVD prevention trial
View PublicationEstimating, across four health conditions, the magnitude of the association between scores derived from the Patient Generated Index (PGI) and those from fully standardized generic and disease-specific measures of the HRQL; to identify the extent to which the areas generated from the PGI are covered by the content of the fully standardized measures
View PublicationDeveloping a framework that characterizes patient transitions among states of HIV clinical care
View PublicationGenerating pilot data comparing bone density, structure, and strength between HIV-infected adults with and without a prior fracture
View PublicationComparing time to virological suppression and rebound between Indigenous and non-Indigenous individuals living with HIV in Canada initiating combination antiretroviral therapy (cART)
View PublicationMeasuring lifetime prevalence, type, and correlates of trauma experience by gender among adolescents living in the HIV hyper-endemic setting of Soweto, South Africa
View PublicationIllustrating the application of empirically supported therapy techniques to reduce condomless anal sex for HIV-positive gay and bisexual men.
View Publication